Skip to main content
SpringerLink
Log in

Epidemiology of Thyroid Cancer

  • Chapter
  • First Online:
The Thyroid and Its Diseases

Abstract

Thyroid cancer is the most common endocrine malignancy. The major histologic subtypes for thyroid cancer is papillary, follicular, medullary, and anaplastic accounting for 80%, 10%, 5%, and < 2%, respectively. The incidence of thyroid cancer has been increasing exponentially with approximately 53,990 new cases being expected to be diagnosed in the USA in 2018. Because of the rising incidence and the good prognosis of thyroid cancer, prevalence rates are significantly higher than incidence with rates ranging from 0.03 to 36%. The mortality of thyroid cancer has remained relatively stable, despite an annual percent increase of 0.82% of rates in the USA from 1992 to 2012. Risk factors for thyroid cancer are also being reviewed in this chapter. Finally, the issue of overdiagnosis of thyroid cancer is addressed in the chapter. We believe that the increased incidence is likely the result of two coexisting processes: increased detection (apparent increase) and increased number of cases (true increase) due to unrecognized thyroid-specific carcinogens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. World Health Organization. 2013. http://globocan.iarc.fr/Pages/summary_table_pop_prev_sel.aspx.

  2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–7.

    Article  CAS  PubMed  Google Scholar 

  3. SEER Stat Fact Sheets. http://seer.cancer.gov/statfacts/html/thyro.html. Accessed 20 June 2018.

  4. Smittenaar CR, Petersen KA, Stewart K, et al. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115:1147–55.

    Article  CAS  PubMed  Google Scholar 

  5. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.

    Article  CAS  Google Scholar 

  6. La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015;136:2187–95.

    Article  PubMed  Google Scholar 

  7. Blomberg M, Feldt-Rasmussen U, Andersen KK, et al. Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer. 2012;131:2360–6.

    Article  CAS  PubMed  Google Scholar 

  8. Scheiden R, Keipes M, Bock C, et al. Thyroid cancer in Luxembourg: a national population-based data report (1983-1999). BMC Cancer. 2006;6:102.

    Article  PubMed  Google Scholar 

  9. Colonna M, Bossard N, Guizard AV, et al. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris). 2010;71:95–101.

    Article  CAS  Google Scholar 

  10. Lise M, Franceschi S, Buzzoni C, et al. Changes in the incidence of thyroid cancer between 1991 and 2005 in Italy: a geographical analysis. Thyroid. 2012;22:27–34.

    Article  Google Scholar 

  11. Pandeya N, McLeod DS, Balasubramaniam K, et al. Increasing thyroid cancer incidence in Queensland, Australia 1982-2008—true increase or overdiagnosis? Clin Endocrinol. 2015. https://doi.org/10.1111/cen.12724. [Epub ahead of print].

    Article  Google Scholar 

  12. Keinan-Boker L, Silverman BG. Trends of thyroid cancer in Israel: 1980–2012. Rambam Maimonides Med J. 2016;7:e0001.

    Article  PubMed  Google Scholar 

  13. Wang Y, Wang W. Increasing incidence of thyroid cancer in shanghai, China, 1983–2007. Asia Pac J Public Health. 2015;27:NP223–9.

    Article  Google Scholar 

  14. Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer ‘epidemic’—screening and overdiagnosis. N Engl J Med. 2014;371:1765–7.

    Article  Google Scholar 

  15. Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;177:1357–61.

    Article  PubMed  Google Scholar 

  16. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomark Prev. 2009;18:784–91.

    Article  Google Scholar 

  17. Veiga LH, Neta G, Aschebrook-Kilfoy B, et al. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the U.S. SEER program, 1997–2008. Thyroid. 2013;23:748–57.

    Article  PubMed  Google Scholar 

  18. Parkin DM, Stiller CA, Draper GJ, et al. International incidence of childhood cancer. IARC Sci Publ. 1988;87:1–401.

    Google Scholar 

  19. Hogan AR, Zhuge Y, Perez EA, et al. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156:167.

    Article  PubMed  Google Scholar 

  20. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer statistics review, 1973–1998. Bethesda: National Cancer Institute; 2001. http://seer.cancer.gov/Publications/CSR1973_1998/

    Google Scholar 

  21. Data from the National Cancer Intelligence Network (UK). www.ncin.org.uk/databriefings. Accessed 15 June 2016.

  22. Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control. 2009;20:525–31.

    Article  Google Scholar 

  23. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, Vol. IX. IARC scientific publications no. 160. Lyon: IARC Press; 2007.

    Google Scholar 

  24. Bertakis KD, Azari R, Helms J, et al. Gender differences in the utilization of health care services. J Fam Pract. 2000;49:147–52.

    CAS  Google Scholar 

  25. Kaplan SH, Gandek B, Greenfield S, et al. Patient and visit characteristics related to physicians’ participatory decision-making style. Med Care. 1995;33:1176–87.

    Article  CAS  Google Scholar 

  26. Yao R, Chiu CG, Strugnell SS, et al. Gender differences in thyroid cancer. Expert Rev Endocrinol Metab. 2011;6:215–43.

    Article  Google Scholar 

  27. Aschebrook-Kilfoy B, Kaplan EL, Chiu BC, et al. The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States. Ann Surg Oncol. 2013;20:2746–53.

    Article  Google Scholar 

  28. Horn-Ross PL, Lichtensztajn DY, Clarke CA, et al. Continued rapid increase in thyroid cancer incidence in California: trends by patient, tumor, and neighborhood characteristics. Cancer Epidemiol Biomark Prev. 2014;23:1067–79.

    Article  Google Scholar 

  29. Vigneri R, Malandrino P, Vigneri P. The changing epidemiology of thyroid cancer: why is incidence increasing? Curr Opin Oncol. 2015;27:1–7.

    Article  Google Scholar 

  30. Mortensen JD, Bennett WA, Woolner LB. Incidence of carcinoma in thyroid glands removed at 1000 consecutive routine necropsies. Surg Forum. 1955;5:659–63.

    CAS  PubMed  Google Scholar 

  31. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid: a “normal” finding in Finland—a systematic autopsy study. Cancer. 1985;56:531–8.

    Article  CAS  PubMed  Google Scholar 

  32. Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J, et al. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer. 1993;71:4022–9.

    Article  CAS  PubMed  Google Scholar 

  33. Seta K, Takahashi S. Thyroid carcinoma. Int Surg. 1976;61:541–4.

    CAS  PubMed  Google Scholar 

  34. Chong PY. Thyroid carcinomas in Singapore autopsies. Pathology. 1994;26:20–2.

    Article  CAS  PubMed  Google Scholar 

  35. Lang W, Borrusch H, Bauer L. Occult carcinomas of the thyroid: evaluation of 1,020 sequential autopsies. Am J Clin Pathol. 1988;90:72–6.

    Article  CAS  PubMed  Google Scholar 

  36. Mitselou A, Vougiouklakis T, Peschos D, et al. Occult thyroid carcinoma: a study of 160 autopsy cases—the first report for the region of Epirus-Greece. Anticancer Res. 2002;22:427–32.

    PubMed  Google Scholar 

  37. Silverberg SG, Vidone RA. Carcinoma of the thyroid in surgical and postmortem material: analysis of 300 cases at autopsy and literature review. Ann Surg. 1966;164:291–9.

    Article  CAS  PubMed  Google Scholar 

  38. Furuya-Kanamori L, Bell KJ, Clark J, et al. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin Oncol. 2016; pii: JCO677419. [Epub ahead of print].

    Google Scholar 

  39. Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. 2011;96:E109–13.

    Article  CAS  PubMed  Google Scholar 

  40. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.

    Article  CAS  PubMed  Google Scholar 

  41. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer statistics review, 1975–2013. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016.

  42. Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/thyroid-cancer/mortality#ref-1. Accessed 15 June 2016.

  43. Sciuto R, Romano L, Rea S, et al. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol. 2009;20:1728–35.

    Article  CAS  PubMed  Google Scholar 

  44. Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid. 2016;26:150–5.

    Article  PubMed  Google Scholar 

  45. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26:1–133.

    Article  PubMed  Google Scholar 

  46. Sarma M, Sonik B, Subramanyam P, et al. Isolated skeletal muscle metastatic deposit in a patient with micropapillary carcinoma thyroid identified by 18F FDG PET CT. J Egypt Natl Canc Inst. 2015;27:47–50.

    Article  PubMed  Google Scholar 

  47. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.

    Article  PubMed  Google Scholar 

  48. Mazzaferri EL. Thyroid cancer. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 3rd ed. Philadelphia: Lippincott, Wiiliams and Wilkins; 2001. p. 382–402.

    Google Scholar 

  49. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12:245–62.

    Article  CAS  PubMed  Google Scholar 

  50. Fukahori M, Yoshida A, Hayashi H, et al. The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort. Thyroid. 2012;22:683–9.

    Article  CAS  PubMed  Google Scholar 

  51. Lohrs U, Permanetter W, Spelsberg F, et al. Investigation of frequency and spreading of the different histological types of thyroid cancer in an endemic goiter region. Verh Dtsch Ges Pathol. 1977;61:268–74.

    CAS  Google Scholar 

  52. Hrafnkelsson J, Jonasson JG, Sigurdsson G, et al. Thyroid cancer in Iceland 1955-1984. Acta Endocrinol. 1988;118:566–72.

    Article  CAS  Google Scholar 

  53. Hadoux J, Pacini F, Tuttle RM, et al. Management of advanced medullary thyroid cancer. Lancet Diabetes Endocrinol. 2016;4:64–71.

    Article  CAS  Google Scholar 

  54. Nosé V. Familial thyroid cancer: a review. Mod Pathol. 2011;24(Suppl 2):S19–33.

    Article  Google Scholar 

  55. Emmertsen K. Medullary thyroid carcinoma and calcitonin. Dan Med Bull. 1985;32:1–28.

    CAS  Google Scholar 

  56. Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567.

    Article  PubMed  Google Scholar 

  57. Smallridge RC, Copland JA. Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. Clin Oncol. 2010;22:486–97.

    Article  CAS  Google Scholar 

  58. Neff RL, Farrar WB, Kloos RT, et al. Anaplastic thyroid cancer. Endocrinol Metab Clin N Am. 2008;37:525–38.

    Article  Google Scholar 

  59. Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103:1330–5.

    Article  PubMed  Google Scholar 

  60. Nagaiah G, Hossain A, Mooney CJ, et al. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol. 2011;2011:542358.

    Article  PubMed  Google Scholar 

  61. Wang SA, Rahemtullah A, Faquin WC, et al. Hodgkin’s lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Mod Pathol. 2005;18:1577.

    Article  Google Scholar 

  62. Pedersen RK, Pedersen NT. Primary non-Hodgkin’s lymphoma of the thyroid gland: a population based study. Histopathology. 1996;28:25.

    Article  CAS  PubMed  Google Scholar 

  63. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29:252.

    Article  CAS  PubMed  Google Scholar 

  64. Logue JP, Hale RJ, Stewart AL, et al. Primary malignant lymphoma of the thyroid: a clinicopathological analysis. Int J Radiat Oncol Biol Phys. 1992;22:929.

    Article  CAS  Google Scholar 

  65. Skarsgard ED, Connors JM, Robins RE. A current analysis of primary lymphoma of the thyroid. Arch Surg. 1991;126:1199.

    Article  CAS  PubMed  Google Scholar 

  66. Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Nat Clin Pract Endocrinol Metab. 2005;1:82.

    Article  Google Scholar 

  67. Bounacer A, Wicker R, Caillou B, et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 1997;15:1263.

    Article  CAS  Google Scholar 

  68. Navas-Carrillo D, Ríos A, Rodríguez JM, et al. Familial nonmedullary thyroid cancer: screening, clinical, molecular and genetic findings. Biochim Biophys Acta. 2014;1846:468–76.

    CAS  Google Scholar 

  69. Holm LE, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985;312:601.

    Article  CAS  PubMed  Google Scholar 

  70. Wartofsky L. Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones (Athens). 2010;9:103–8.

    Article  Google Scholar 

  71. Knobel M, Medeiros-Neto G. Relevance of iodine intake as a reputed predisposing factor for thyroid cancer. Arq Bras Endocrinol Metabol. 2007;51:701–12.

    Article  PubMed  Google Scholar 

  72. Marcello MA, Sampaio AC, Geloneze B, et al. Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer. 2012;64:1190–5.

    Article  CAS  PubMed  Google Scholar 

  73. Meinhold CL, Ron E, Schonfeld SJ, et al. Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. Am J Epidemiol. 2010;171:242–52.

    Article  PubMed  Google Scholar 

  74. Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case–control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14:773–85.

    Article  PubMed  Google Scholar 

  75. Sokić SI, Adanja BJ, Vlajinac HD, et al. Risk factors for thyroid cancer. Neoplasma. 1994;41:371–4.

    PubMed  Google Scholar 

  76. Duntas LH, Doumas C. The ‘rings of fire’ and thyroid cancer. Hormones (Athens). 2009;8:249–53.

    Article  Google Scholar 

  77. Jensen K, Patel A, Larin A, et al. Human herpes simplex viruses in benign and malignant thyroid tumours. J Pathol. 2010;221:193–200.

    Article  CAS  PubMed  Google Scholar 

  78. Almeida JM, Marcello M, Bufalo N, et al. EBV may play a role in the development of thyroid nodules. Presented in 83rd Annual Meeting of the American Thyroid Association, p. A-88. San Juan, Porto Rico: Thyroid; 2013.

    Google Scholar 

  79. Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism. Horm Metab Res. 2012;44:255–62.

    Article  CAS  Google Scholar 

  80. Sokal JE. Incidence of malignancy in toxic and non-toxic nodular goiter. JAMA. 1954;154:1321–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, USA

    Athanasios Bikas

  2. Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, MedStar Washington Hospital Center, Washington, DC, USA

    Kenneth D. Burman

Authors
  1. Athanasios Bikas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth D. Burman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kenneth D. Burman .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine, Philipps University Marburg, Marburg, Germany

    Markus Luster

  2. Unit of Endocrinology Diabetes and Metabolism, Evgenidion Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Leonidas H. Duntas

  3. Georgetown University School of Medicine, Washington, DC, USA

    Leonard Wartofsky

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bikas, A., Burman, K.D. (2019). Epidemiology of Thyroid Cancer. In: Luster, M., Duntas, L., Wartofsky, L. (eds) The Thyroid and Its Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-72102-6_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72102-6_35

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72100-2

  • Online ISBN: 978-3-319-72102-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation